BridgeMD
Compares treatment options for Pilonidal Disease
Official title Effect of Antiseptic Irrigations With 0.05% Chlorhexidine Gluconate (Irrisept) Versus Normal Saline on Fasciocutaneous Flap-Based Closure of Pilonidal Disease
ClinicalTrials.gov ID: NCT07321704
What this study is testing
- What it's testing
- Pilonidal disease is a chronic condition that causes painful inflammation and infection near the top of the buttocks. Many patients require surgery, and one commonly used approach is a bilateral gluteal fasciocutaneous flap with midline closure along with placement of an extracellular matrix to support wound healing.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Willing and able to provide written informed consent and to comply with the requirements of the Clinical Investigational Plan
- Male or female patients aged 18 years or above
- Patients scheduled for flap-based procedure for pilonidal disease with planned use of Irrisept or normal saline irrigation
- people who are willing and able to comply with all aspects of the treatment and evaluation schedule
You likely can't join if
- Known allergy to contents of Irrisept (chlorhexidine gluconate)
- Full-thickness ('third degree') burns
- Wounds with uncontrolled clinical infection (CDC Contamination Grade 4)
- Any medical condition or serious intercurrent illness that, in the opinion of the investigator, may make it undesirable for the patient to...
- Currently participating or has participated in another clinical study within 30 days prior to enrollment
- Pregnant or lactating women
See the full eligibility criteria
- Willing and able to provide written informed consent and to comply with the requirements of the Clinical Investigational Plan
- Male or female patients aged 18 years or above
- Patients scheduled for flap-based procedure for pilonidal disease with planned use of Irrisept or normal saline irrigation
- people who are willing and able to comply with all aspects of the treatment and evaluation schedule
- Known allergy to contents of Irrisept (chlorhexidine gluconate)
- Full-thickness ('third degree') burns
- Wounds with uncontrolled clinical infection (CDC Contamination Grade 4)
- Any medical condition or serious intercurrent illness that, in the opinion of the investigator, may make it undesirable for the patient to participate in the study
- Currently participating or has participated in another clinical study within 30 days prior to enrollment
- Pregnant or lactating women
- Any subject who, at the discretion of the Investigator, is not suitable for inclusion in the study
The study team makes the final eligibility decision.
Where it's taking place
- Los Angeles, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Los Angeles, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.